Any feedback?
No. of entries
Information on EC 1.5.1.1 - 1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase [NAD(P)H]
for references in articles please use BRENDA:EC1.5.1.1
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree 1 Oxidoreductases
1.5 Acting on the CH-NH group of donors
1.5.1 With NAD+ or NADP+ as acceptor
1.5.1.1 1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase [NAD(P)H]
IUBMB Comments
The enzymes, characterized from the bacterium Azospirillum brasilense, is involved in trans-3-hydroxy-L-proline metabolism. In contrast to EC 1.5.1.21, 1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase (NADPH), which is specific for NADPH, this enzyme shows similar activity with NADPH and NADH.
The expected taxonomic range for this enzyme is: Bacteria, Eukaryota
- 1.5.1.1
-
nadph-dependent
- cerebral
- dehydratase
- trans-3-hydroxy-l-proline
- d-lysine
- archaeon
- d-proline
- litoralis
-
extracerebral
-
forebrain
-
thermococcus
- saccharopine
-
ovine
- reductases
- collagen
Reaction Schemes
showSynonyms
pycr2, mu-crystallin, thyroid hormone binding protein, ketimine reductase, cytosolic thyroid hormone binding protein, pyr2c reductase, p2c/pyr2c reductase, delta1-pyrroline-2-carboxylate reductase, p2c reductase, more
topPlease wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYNONYM 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
DELTA1-Pyr2C reductase
DELTA1-pyrroline-2-carboxylate reductase
ketimine reductase
L-proline:NAD(P)+ 2-oxidoreductase
-
-
-
-
P2C reductase
P2C/Pyr2C reductase
Pyr2C reductase
pyrroline-2-carboxylate reductase
-
-
-
-
reductase, pyrroline-2-carboxylate
-
-
-
-
DELTA1-pyrroline-2-carboxylate reductase
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REACTION
REACTION DIAGRAM
COMMENTARY
ORGANISM
UNIPROT
LITERATURE
L-pipecolate + NAD(P)+ = 1-piperideine-2-carboxylate + NAD(P)H + H+
(1)
-
-
-
L-pipecolate + NAD(P)+ = 1-piperideine-2-carboxylate + NAD(P)H + H+
(1) proposed catalytic mechanism of ketimine reductase
L-proline + NAD(P)+ = 1-pyrroline-2-carboxylate + NAD(P)H + H+
Mobile domains I and II of protein change their conformations to produce the catalytic form. Preference for NADPH over NADH is explained by the cofactor binding site architecture
L-proline + NAD(P)+ = 1-pyrroline-2-carboxylate + NAD(P)H + H+
(2)
-
-
-
L-proline + NAD(P)+ = 1-pyrroline-2-carboxylate + NAD(P)H + H+
(2) proposed catalytic mechanism of ketimine reductase
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
oxidation
-
-
-
-
redox reaction
-
-
-
-
reduction
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PATHWAY SOURCE
PATHWAYS
BRENDA
KEGG
MetaCyc
L-lysine degradation II (L-pipecolate pathway), L-lysine degradation V, L-proline biosynthesis IV, N-hydroxy-L-pipecolate biosynthesis, trans-3-hydroxy-L-proline degradation
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYSTEMATIC NAME
IUBMB Comments
L-pipecolate/L-proline:NAD(P)+ 2-oxidoreductase
The enzymes, characterized from the bacterium Azospirillum brasilense, is involved in trans-3-hydroxy-L-proline metabolism. In contrast to EC 1.5.1.21, 1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase (NADPH), which is specific for NADPH, this enzyme shows similar activity with NADPH and NADH.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CAS REGISTRY NUMBER
COMMENTARY
9029-16-7
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBSTRATE
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
LITERATURE
COMMENTARY
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
(4R)-DELTA1-pyrroline-4-hydroxy-2-carboxylate + NADPH + H+
(4R)-4-hydroxy-L-proline + NADP+
Substrates: -
Products: -
Products: -
r
1-pyrroline-(4R)-hydroxy-2-carboxylate + NADPH + H+
(4R)-hydroxy-L-proline + NADP+
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NADPH + H+
L-proline + NADP+
Substrates: -
Products: -
Products: -
?
cis-3-hydroxy-L-proline + NADP+
? + NADPH + H+
Substrates: low activity
Products: -
Products: -
r
cis-4-hydroxy-L-proline + NADP+
? + NADPH + H+
Substrates: low activity
Products: -
Products: -
r
DELTA1-piperideine 2-carboxylate + NADH + H+
L-pipecolate + NAD+
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-(4R)-hydroxy-2-carboxylate + NADPH + H+
(4R)-hydroxy-L-proline + NADP+
Substrates: -
Products: -
Products: -
r
DELTA2-thiazoline-2-carboxylate + NADPH + H+
? + NADP+
Substrates: -
Products: -
Products: -
?
L-pipecolate + NAD(P)+
1-piperideine-2-carboxylate + NAD(P)H + H+
Substrates: -
Products: -
Products: -
r
L-pipecolic acid + NAD(P)+
DELTA1-piperidine-2-carboxylate + NAD(P)H
-
Substrates: at 26% of the rate with L-proline
Products: -
Products: -
r
L-proline + NAD(P)+
1-pyrroline-2-carboxylate + NAD(P)H + H+
Substrates: -
Products: -
Products: -
r
L-proline + NAD(P)+
DELTA1-pyrroline-2-carboxylate + NAD(P)H + H+
-
Substrates: -
Products: -
Products: -
r
trans-4-hydroxy-L-proline + NADP+
? + NADPH + H+
Substrates: low activity
Products: -
Products: -
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
Substrates: -
Products: -
Products: -
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
Substrates: -
Products: -
Products: -
?
1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
-
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
-
Substrates: -
Products: -
Products: -
r
DELTA1-piperideine 2-carboxylate + NADPH + H+
L-pipecolate + NADP+
Substrates: -
Products: -
Products: -
?
DELTA1-piperideine 2-carboxylate + NADPH + H+
L-pipecolate + NADP+
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
Cercocebus sp.
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-piperidine-2-carboxylate + NADH + H+
L-pipecolate + NAD+
Substrates: -
Products: -
Products: -
r
DELTA1-piperidine-2-carboxylate + NADH + H+
L-pipecolate + NAD+
Substrates: -
Products: -
Products: -
r
DELTA1-piperidine-2-carboxylate + NADPH + H+
L-pipecolate + NADP+
Substrates: -
Products: -
Products: -
r
DELTA1-piperidine-2-carboxylate + NADPH + H+
L-pipecolate + NADP+
Substrates: -
Products: -
Products: -
r
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
Cercocebus sp.
-
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: at 55% of the rate with DELTA1-piperidine-2-carboxylate
Products: -
Products: -
r
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
Substrates: -
Products: -
Products: -
r
DELTA1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
Substrates: -
Products: -
Products: -
r
DELTA1-pyrroline-2-carboxylate + NADPH + H+
L-proline + NADP+
Substrates: -
Products: -
Products: -
r
DELTA1-pyrroline-2-carboxylate + NADPH + H+
L-proline + NADP+
Substrates: -
Products: -
Products: -
r
L-pipecolate + NAD+
DELTA1-piperidine-2-carboxylate + NADH + H+
Substrates: -
Products: -
Products: -
r
L-pipecolate + NAD+
DELTA1-piperidine-2-carboxylate + NADH + H+
Substrates: -
Products: -
Products: -
r
L-pipecolate + NADP+
DELTA1-piperidine-2-carboxylate + NADPH + H+
Substrates: -
Products: -
Products: -
r
L-pipecolate + NADP+
DELTA1-piperidine-2-carboxylate + NADPH + H+
Substrates: -
Products: -
Products: -
r
L-proline + NAD+
DELTA1-pyrroline-2-carboxylate + NADH + H+
Substrates: -
Products: -
Products: -
r
L-proline + NAD+
DELTA1-pyrroline-2-carboxylate + NADH + H+
Substrates: -
Products: -
Products: -
r
L-proline + NADP+
DELTA1-pyrroline-2-carboxylate + NADPH + H+
Substrates: -
Products: -
Products: -
r
L-proline + NADP+
DELTA1-pyrroline-2-carboxylate + NADPH + H+
Substrates: -
Products: -
Products: -
r
additional information
?
-
Substrates: trans-3-hydroxy-L-proline is converted to proline by the purified LhpH and LhpI proteins, i.e. trans-3-hydroxy-L-proline dehydratase and DELTA1-pyrroline-2-carboxylate reductase, at pH 7.0. LhpI has dual metabolic functions as a reductase for DELTA1-pyrroline-2-carboxylate and DELTA1-piperidine-2-carboxylate
Products: -
Products: -
?
additional information
?
-
-
Substrates: trans-3-hydroxy-L-proline is converted to proline by the purified LhpH and LhpI proteins, i.e. trans-3-hydroxy-L-proline dehydratase and DELTA1-pyrroline-2-carboxylate reductase, at pH 7.0. LhpI has dual metabolic functions as a reductase for DELTA1-pyrroline-2-carboxylate and DELTA1-piperidine-2-carboxylate
Products: -
Products: -
?
additional information
?
-
Substrates: no activity with trans-4-hydroxy-D-proline, D-proline, trans-3-hydroxy-L-proline, cis-4-hydroxy-D-proline, and cis-3-hydroxy-D-proline, poor activity with trans-4-hydroxy-L-proline
Products: -
Products: -
?
additional information
?
-
-
Substrates: no activity with trans-4-hydroxy-D-proline, D-proline, trans-3-hydroxy-L-proline, cis-4-hydroxy-D-proline, and cis-3-hydroxy-D-proline, poor activity with trans-4-hydroxy-L-proline
Products: -
Products: -
?
additional information
?
-
Substrates: reciprocal relationship between thyroid hormone binding and DELTA1-piperideine-2-carboxylate (P2C) binding to ketimine reductase
Products: -
Products: -
-
additional information
?
-
-
Substrates: reciprocal relationship between thyroid hormone binding and DELTA1-piperideine-2-carboxylate (P2C) binding to ketimine reductase
Products: -
Products: -
-
additional information
?
-
Substrates: purified recombinant human CRYM possesses substantial KR activity. Ketimine reductase is a typical imine reductase. Substrate specificity of recombinant human ketimine reductase (KR) toward DELTA1-piperideine-2-carboxylate (P2CR) and various noncyclized imine intermediates, overview. N-methyl-L-alanine is produced when human KR is incubated in the presence of methylamine, NADPH and pyruvate. Human KR catalyzes the reductive alkylamination of phenylpyruvate and glyoxylate in the presence of methylamine. Substrate docking
Products: -
Products: -
-
additional information
?
-
-
Substrates: purified recombinant human CRYM possesses substantial KR activity. Ketimine reductase is a typical imine reductase. Substrate specificity of recombinant human ketimine reductase (KR) toward DELTA1-piperideine-2-carboxylate (P2CR) and various noncyclized imine intermediates, overview. N-methyl-L-alanine is produced when human KR is incubated in the presence of methylamine, NADPH and pyruvate. Human KR catalyzes the reductive alkylamination of phenylpyruvate and glyoxylate in the presence of methylamine. Substrate docking
Products: -
Products: -
-
additional information
?
-
-
Substrates: involved in the catabolism of D-lysine and D-proline
Products: -
Products: -
?
additional information
?
-
-
Substrates: reverse reactions oxidizing L-proline or L-pipecolic acid are catalyzed at much lower rates. Very poor substrates: trans-4-hydroxy-L-proline, L-thioproline
Products: -
Products: -
?
additional information
?
-
-
Substrates: the enzyme from kidney shows no activity with DELTA1-pyrroline-5-carboxylate and DELTA1-piperideine-6-carboxylate
Products: -
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
LITERATURE
COMMENTARY
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
Substrates: -
Products: -
Products: -
?
1-pyrroline-2-carboxylate + NADPH + H+
L-proline + NADP+
Substrates: -
Products: -
Products: -
?
DELTA1-piperideine 2-carboxylate + NADH + H+
L-pipecolate + NAD+
Substrates: -
Products: -
Products: -
?
DELTA2-thiazoline-2-carboxylate + NADPH + H+
? + NADP+
Substrates: -
Products: -
Products: -
?
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
Substrates: -
Products: -
Products: -
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
r
DELTA1-piperideine 2-carboxylate + NADPH + H+
L-pipecolate + NADP+
Substrates: -
Products: -
Products: -
?
DELTA1-piperideine 2-carboxylate + NADPH + H+
L-pipecolate + NADP+
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
Cercocebus sp.
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
Cercocebus sp.
-
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
Substrates: -
Products: -
Products: -
ir
additional information
?
-
Substrates: trans-3-hydroxy-L-proline is converted to proline by the purified LhpH and LhpI proteins, i.e. trans-3-hydroxy-L-proline dehydratase and DELTA1-pyrroline-2-carboxylate reductase, at pH 7.0. LhpI has dual metabolic functions as a reductase for DELTA1-pyrroline-2-carboxylate and DELTA1-piperidine-2-carboxylate
Products: -
Products: -
?
additional information
?
-
-
Substrates: trans-3-hydroxy-L-proline is converted to proline by the purified LhpH and LhpI proteins, i.e. trans-3-hydroxy-L-proline dehydratase and DELTA1-pyrroline-2-carboxylate reductase, at pH 7.0. LhpI has dual metabolic functions as a reductase for DELTA1-pyrroline-2-carboxylate and DELTA1-piperidine-2-carboxylate
Products: -
Products: -
?
additional information
?
-
Substrates: reciprocal relationship between thyroid hormone binding and DELTA1-piperideine-2-carboxylate (P2C) binding to ketimine reductase
Products: -
Products: -
-
additional information
?
-
-
Substrates: reciprocal relationship between thyroid hormone binding and DELTA1-piperideine-2-carboxylate (P2C) binding to ketimine reductase
Products: -
Products: -
-
additional information
?
-
-
Substrates: involved in the catabolism of D-lysine and D-proline
Products: -
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
COFACTOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
additional information
-
NADH and NADPH are equally effective as cofactor for the enzyme purified from rat kidney
-
additional information
-
the enzyme purified from porcine kidney shows equal activity with NADPH and NADH
-
additional information
the enzyme shows dual specificity for NADPH and NADH
-
additional information
-
the enzyme shows dual specificity for NADPH and NADH
-
additional information
the enzyme uses NADH and NADPH as reductant about equally well
-
additional information
-
the enzyme uses NADH and NADPH as reductant about equally well
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
N-formyl-L-methionine
-
non competitive inhibition, EDTA decreases the inhibition rate
additional information
the P2C reductase activity is potently inhibited by thyroid hormones
-
additional information
-
the P2C reductase activity is potently inhibited by thyroid hormones
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
African Swine Fever
African Swine Fever Virus Protein E199L Promotes Cell Autophagy through the Interaction of PYCR2.
Brain Diseases
Loss of PYCR2 Causes Neurodegeneration by Increasing Cerebral Glycine Levels via SHMT2.
Carcinogenesis
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Carcinoma, Hepatocellular
Molecular cloning of cDNA encoding a 55-kDa multifunctional thyroid hormone binding protein of skeletal muscle sarcoplasmic reticulum.
Carcinoma, Hepatocellular
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Carcinoma, Squamous Cell
An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1, 6-bisphosphate.
Carcinoma, Squamous Cell
Characterization of a membrane-associated 3,3',5-triiodo-L-thyronine binding protein by use of monoclonal antibodies.
Choriocarcinoma
Regulation of thyroid hormone receptor-mediated transcription by a cytosol protein.
Colonic Neoplasms
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Deafness
CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.
Deafness
Spiking Expression of mu-Crystallin mRNA during Treatment with Methimazole in Patients with Graves' Hyperthyroidism.
Hearing Loss
CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.
Hyperglycemia
Hyperglycemia induces elevated expression of thyroid hormone binding protein in vivo in kidney and heart and in vitro in mesangial cells.
Hyperglycemia
Loss of PYCR2 Causes Neurodegeneration by Increasing Cerebral Glycine Levels via SHMT2.
Hyperkinesis
PYCR2 Mutations cause a lethal syndrome of microcephaly and failure to thrive.
Hypersensitivity
PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress.
Hyperthyroidism
Concentration of serum thyroid hormone binding proteins after 131I treatment of hyperthyroidism.
Hyperthyroidism
Measurement of serum thyroxine binding prealbumin in various thyroidal states by radioimmunoassay.
Hyperthyroidism
Spiking Expression of mu-Crystallin mRNA during Treatment with Methimazole in Patients with Graves' Hyperthyroidism.
Hyperthyroidism
[Improved thyroid diagnosis in borderline hyperthyroidism by determination of free T3 index]
Infections
African Swine Fever Virus Protein E199L Promotes Cell Autophagy through the Interaction of PYCR2.
Melanoma
Downregulation of pyrroline-5-carboxylate reductase-2 induces the autophagy of melanoma cells via AMPK/mTOR pathway.
Melanoma
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Microcephaly
Expanding the genotypic spectrum of PYCR2 and a common ancestry in Thai patients with hypomyelinating leukodystrophy 10.
Microcephaly
Loss of PYCR2 Causes Neurodegeneration by Increasing Cerebral Glycine Levels via SHMT2.
Microcephaly
Mutations in PYCR2, Encoding Pyrroline-5-Carboxylate Reductase 2, Cause Microcephaly and Hypomyelination.
Microcephaly
PYCR2 Mutations cause a lethal syndrome of microcephaly and failure to thrive.
Movement Disorders
Expanding the genotypic spectrum of PYCR2 and a common ancestry in Thai patients with hypomyelinating leukodystrophy 10.
Muscle Hypotonia
PYCR2 Mutations cause a lethal syndrome of microcephaly and failure to thrive.
Muscular Diseases
Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy.
Muscular Dystrophies
Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy.
Muscular Dystrophy, Facioscapulohumeral
Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy.
Neoplasm Metastasis
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Neoplasm Metastasis
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Neoplasms
Moderate-Intensity Exercise Induces Neurogenesis and Improves Cognition in Old Mice by Upregulating Hippocampal Hippocalcin, Otub1, and Spectrin-?.
Neoplasms
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Neoplasms
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Paraplegia
Spastic paraplegia as the only symptom in two adult-onset patients carrying a novel pathogenic variant in PYCR2.
Spinal Cord Injuries
Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice.